Abstract
The execution phase of apoptosis occurs through the activation and function of caspases which cleave key substrates that orchestrate the death process. Here, we have compared the sensitivity of various T and B cell lines to death receptor or staurosporine-induced apoptosis. First, we found a lack of correlation between death receptor expression and sensitivity to Fas or Trail. By contrast, a correlation between caspase activation, DNA fragmentation and cell death in T cell lines was evidenced. Among T cells, CEM underwent apoptosis in response to CH11 but were resistant to Trail in agreement with the absence of Trail receptors (DR4 and DR5) on their surface. The B cell line SKW 6.4 was sensitive to CH11 and staurosporine but resistant to Trail. As B cell lines expressed significant levels of DR4 and DR5, resistance to Trail in SKW 6.4 is likely due to the expression of the decoy receptor DcR1. Burkitt's lymphoma such as RPMI 8866 and Raji did not exhibit DNA fragmentation in response to CH11, Trail or staurosporine but showed long-term caspase-dependent loss of viability upon effector treatment. The B cell lines used in this study express very weak or undetectable levels of DFF40 and relatively high levels of DFF45. Interestingly, cytosolic extracts from RPMI 88.66 but not other B lymphoma exhibit altered levels of cytochrome c-dependent caspase activation. Taken together, our results show that: (1) death receptor expression does not correlate with sensitivity to apoptosis; (2) the very low ratio of DFF40 vs DFF45 is unlikely to explain by itself the lack of DNA fragmentation observed in certain B cell lines; and (3) a defective cytochrome c-dependent caspase activation might account at least in part for the insensitivity of certain Burkitt's lymphoma (RPMI 88.66) to apoptosis. Thus it seems that resistance of Burkitt's lymphoma to apoptosis is not governed by a general mechanism, but is rather multifactorial and differs from one cell line to another.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Thompson CB . Apoptosis in the pathogenesis and treatment of disease Science 1995 267: 1456–1462
Nagata S . Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model J Hum Genet 1998 43: 2–8
Vaux DL, Cory S, Adams JM . Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells Nature 1988 335: 440–442
Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ . Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines J Immunol 1990 144: 3602–3610
Campana D, Coustan-Smith E, Manabe A, Buschle M, Raimondi SC, Behm R, Ashmun FG, Arico M, Biondi A, Pui CH . Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein Blood 1993 81: 1025–1031
Ashkenazi A, Dixit VM . Death receptors: signaling and modulation Science 1998 281: 1305–1308
Peter ME, Krammer PH . Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis Curr Opin Immunol 1998 10: 545–551
Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, Dixit VM . FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis J Biol Chem 1996 271: 4961–4965
Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM . FADD, a death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis Cell 1995 81: 502–512
Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevehenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM . FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 1996 85: 817–827
Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM . An induced proximity model for caspase-8 activation J Biol Chem 1998 273: 2926–2930
Hasegawa J, Kamada S, Kamiike W, Shimizu S, Imazu T, Matsuda H, Tsujimoto M . Involvement of CPP32/YAMA (-like) proteases in Fas-mediated apoptosis Cancer Res 1996 56: 1713–1718
Enari M, Talanian RV, Wong WW, Nagata S . Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis Nature 1996 380: 723–726
Dubrez L, Savoy I, Hamman A, Solary E . Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways EMBO J 1996 15: 5504–5512
Juan TS, McNiece IK, Argento JM, Jenkins NA, Gilbert DJ, Copeland NG, Fletcher FA . Identification and mapping of Casp7, a cysteine protease resembling CPP32 beta, interleukin-1 beta converting enzyme, and CED-3 Genomics 1997 40: 86–97
Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S . A caspase activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD Nature 1997 391: 43–50
Sakahira H, Enari M, Nagata S . Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis Nature 1998 391: 96–99
Li LY, Luo X, Wang X . Endonuclease G is an apoptotic DNase when released from mitochondria Nature 2001 412: 95–99
Mari B, Checler F, Ponzio G, Peyron JF, Manie S, Farahifar D, Rossi B, Auberger P . Jurkat T cells express a functional neutral endopeptidase activity (CALLA) involved in T cell activation EMBO J 1992 11: 3875–3885
Bourget I, Di Berardino W, Breittmayer JP, Grenier-Brossette N, Plana-Prades M, Bonnefoy JY, Cousin JL . CD20 monoclonal antibodies stimulate extracellular cleavage of the low affinity receptor for IgE (Fc epsilon RII/CD23) in Epstein-Barr-transformed B cells J Biol Chem 1994 269: 6927–6930
Munoz O, Brignone C, Grenier-Brossette N, Bonnefoy JY, Cousin JL . Binding of anti-CD23 monoclonal antibody to the leucine zipper motif of FcepsilonRII/CD23 on B cell membrane promotes its proteolytic cleavage. Evidence for an effect on the oligomer/monomer equilibrium J Biol Chem 1998 273: 31795–31800
Ricci JE, Maulon L, Luciano F, Guerin S, Livolsi A, Mari B, Breittmayer JP, Peyron JF, Auberger P . Cleavage and relocation of tyrosine kinase P59FYN during Fas-mediated apoptosis in T lymphocytes Oncogene 1999 18: 3963–3969
Bertolotto C, Ricci JE, Luciano F, Mari B, Chambard JC, Auberger P . Cleavage of the serum response factor during death receptor-induced apoptosis results in an inhibition of the c-FOS promoter transcriptional activity J Biol Chem 2000 275: 12941–12947
Mari B, Guerin S, Maulon L, Belhacene N, Farahi Far D, Imbert V, Rossi B, Peyron JF, Auberger P . Endopeptidase 24.11 (CD10/NEP) is required for phorbol ester-induced growth arrest in Jurkat T cells FASEB J 1997 11: 869–879
Guerin S, Mari B, Fernandez E, Belhacene N, Toribio ML, Auberger P . CD10 is expressed on human thymic epithelial cell lines and modulates thymopentin-induced cell proliferation FASEB J 1997 11: 1003–1011
Pages G, Guerin S, Grall D, Bonino F, Smith A, Anjuere F, Auberger P, Pouyssegur J . Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice Science 1999 286: 1374–1377
Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, Peyron JF . Tyrosine phosphorylation of 1 kappa B-alpha activates NF-kappa B without proteolytic degradation of 1 kappa B-alpha Cell 1996 86: 787–798
Maulon L, Guerin S, Ricci JE, Breittmayer DF, Auberger P . T-cell receptor signaling pathway exerts a negative control on thrombin-mediated increase in [Ca2+]i and p38 MAPK activation in Jurkat T cells: implication of the tyrosine kinase p56Lck Blood 1998 91: 4232–4241
Cursio R, Gugenheim J, Ricci JE, Crenesse D, Rostagno P, Maulon L, Saint-Paul MC, Ferrua B, Auberger P . A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis FASEB J 1999 13: 253–261
Wolf BW, Schuler M, Li W, Eggers-Sedlet B, Lee W, Tailor P, Fitzgerald P, Mills GB, Green DG . Defectice cytochrome C-dependent caspase activation in ovarian cancer cell lines due to diminished or absent APAF-1 activity J Biol Chem 2001 276: 34244–34251
Shain KH, Landwoski TH, Buyuksal I, Cantor AB, Dalton WS . Clonal variability in CD9 expression is the major determinant in Fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 multiple myeloma cell line Leukemia 2000 14: 830–840
Tepper CG, Seldin MF . Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein–Barr virus tumorigenesis in Burkitt's lymphoma Blood 1999 94: 1727–1737
Irissari M, Plumas J, Bonnefoix T, Jacob MC, Roucard C, Pasquier MA, Sotto JJ, Lajmanovich A . Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-hodgkin's lymphoma B cell line Leukemia 2000 14: 2149–2158
Zermati Y, Garrido C, Amsellem S, Ffishelson S, Bouscary D, Valensi F, Varet B, Solary E, Hermine O . Caspase activation is required for terminal erythroid differienciation J Exp Med 2001 193: 247–254
De Maria R, Zeuner A, Eramo A, Domenichelli C, Bonci D, Grignani F, Srinivasula SM, Alnemri ES, Testa U, Peschle C . Negative regulation of erythropoiesis by caspase mediated cleavage of GATA-1 Nature 1999 401: 433–435–436
Blagosklonny MV . Cell death beyond apoptosis Leukemia 2000 14: 1502–1508
Sakahira H, Enari M, Ohsawa Y, Uchiyama Y, Nagata S . Apoptotic nuclear morphological change without DNA fragmentation Curr Biol 1999 9: 543–546
Kawabata Y, Hirokawa M, Kitabayashi A, Horiuchi T, Kuroki J, Miura AB . Defective apoptotic signal transduction pathway downstream of caspase-3 in human B-lymphoma cells: a novel mechanism of nuclear apoptosis resistance Blood 1999 94: 3523–3530
Acknowledgements
This work was supported by INSERM, the Fondation de France and the Ligue Nationale Contre le Cancer (Equipe labellisée).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Luciano, F., Ricci, JE., Herrant, M. et al. T and B leukemic cell lines exhibit different requirements for cell death: correlation between caspase activation, DFF40/DFF45 expression, DNA fragmentation and apoptosis in T cell lines but not in Burkitt's lymphoma. Leukemia 16, 700–707 (2002). https://doi.org/10.1038/sj.leu.2402401
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402401
Keywords
This article is cited by
-
The role of the DFF40/CAD endonuclease in genomic stability
Apoptosis (2021)
-
Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression
BMC Cancer (2018)
-
Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis
Cell Death Discovery (2016)
-
Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation
Oncogene (2010)
-
Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins
Cell Death & Disease (2010)